Zantac Recall Cancelled
A 2016 study that found a link between the active ingredient in the heartburn drug Zantac and cancer, leading to its eventual recall, has been retracted.
Earlier Retiree News post on the Zantac recall:
January 12, 2020: The FDA Announces Two More Antacid Recalls Due to Cancer Risk
September 20, 2019: Heartburn Drug Zantac May Contain Small Amounts of Known Carcinogen, FDA Says
Retiree News 
Comments are closed.